RE: It’s a mystery..25 Sep 2025 10:14
I read in a couple of places that it’s a reaction to Oxb still being loss making …”The Oxford, England-based gene and cell therapy developer reported a pretax loss of GBP26.0 million for the six months to the end of June, narrowing from GBP35.7 million a year prior.” Markets maybe expected Oxb to be making a profit by now?
With careful management should see a profit next year but reckon this is only a temporary blip with the sp. Now in the FTSE 250. Agree with dubsy the pharma sector really is in the dumps at the moment.